Expired Tender Czech Republic ICB TOT Ref. 131867993

Medicinal Product for Autologous Cell Therapy Tender - 131867993

Tender notice from Czech Republic, published on 11 Dec 2025.

Executive Summary

The UNIVERSITY HOSPITAL PILSEN has issued a Tender notice for the procurement of a Medicinal Product for Autologous Cell Therapy - Axikabtagen Ciloleucel- 2025 in the Czech Republic. This Tender notice was published on 11 Dec 2025 and is scheduled to close on 13 Jan 2026, with an estimated Tender value of CZK 265548000. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 131867993, while the tender notice number is 824201-2025 and Register on the platform.

Key facts

Summary
Medicinal Product for Autologous Cell Therapy - Axikabtagen Ciloleucel- 2025
TOT Ref. No.
131867993
Document Ref. No.
824201-2025
Country
Czech Republic
Notice type
Tender
Competition
ICB
Publication date
11 Dec 2025
Bid deadline
13 Jan 2026
EMD
Refer Document
Tender value
CZK 265548000
Purchaser ownership
Public
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

The subject of the public contract is the supply of a medicinal product intended for the therapy of malignant blood diseases in the total expected volume of 32 individual doses of the medicinal product. The preparation is intended for the provision of health care at the FN medical workplace Pilsen. Deliveries of the subject of performance will be carried out on the basis of the results of the completed procurement procedure for a period of four years from the signing of the purchase contract. Medicinal product for autologous cell therapy - axikabtagen ciloleucel- 2025 The subject of the public contract is supplies of a medicinal product intended for the therapy of malignant blood diseases in the total expected volume of 32 individual doses of the medicinal product. The preparation is intended for the provision of health care at the medical workplace of the FN Plzeň. Deliveries of the subject of performance will be implemented on the basis of the results of the completed procurement procedure for a period of four years from the signing of the purchase contract. Cytostatic agent for CAR-T therapy (axicabtagen ciloleucel) - infusion bag containing a cell dispersion of 0.4 - 2x10^8 viable anti-CD19 CAR-positive T-lymphocytes. Estimated annual volume is 8 infusion bags containing an individually determined amount of the active ingredient, ATC L01XL03 Doc Title: Medicinal product for autologous cell therapy - axikabtagen ciloleucel- 2025 Contract Type: supplies
Document Type: Contract Notice Reference Number: 72/25 Contract Type: supplies Estimated Value: 265548000 - CZK Authority Type: body-pl-cga Doc Title: Medicinal product for autologous cell therapy - axikabtagen ciloleucel- 2025 Dispatch Date: 2025-12-10 Publish Date: 2025-12-11 Submission Date: 2026-01-13

Documents

Tender Notice
Login to view

Corresponding contract award notice

Similar tenders

Tender Country TOT Ref. No. Bid deadline
Guidewires for Vascular Neurointerventions Czech Republic 152719303 23 Dec 2026
Supply of Immunosuppressive and Immunostimulant Pharmaceuticals for Chronic Disease Therapy ** Czech Republic 152716283 18 Dec 2026
Continuous Supplies of Disposable Paper Towels - Repeating Czech Republic 152713865 21 Dec 2026
Hypertonic Solutions Iii. 2026 Czech Republic 152713583 23 Dec 2026
Uvn-Vofn Prague - Medical Technology - Change - X-Ray Devices C-Arms Rdg Czech Republic 152713461 21 Dec 2026

Czech Republic Public Procurement Intelligence

Frequently asked questions

The bid deadline for Medicinal Product for Autologous Cell Therapy - Axikabtagen Ciloleucel- 2025 was 13 Jan 2026. Bidding is closed.

This tender has been issued by UNIVERSITY HOSPITAL PILSEN in Czech Republic.

The estimated tender value is CZK 265548000. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33652000 - Antineoplastic and immunomodulating agents.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 131867993. The purchaser document reference is 824201-2025.

See the Similar Tenders section on this page or browse other tenders from Czech Republic.

This tender falls under Materials and Products, Technology and Equipment in Czech Republic. Suppliers in these sectors can track similar Czech Republic tenders using CPV-based alerts.